Additional file 1 of Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years
Fields of Study & Subjects
Spondyloarthritis Studies and Treatments
Rheumatoid Arthritis Research and Therapies
Psoriasis: Treatment and Pathogenesis
Publication details
- Journal / source
- Figshare
- Publication date
- 1 January 2026
- Language
- EN